1. Home
  2. CISO vs SCLX Comparison

CISO vs SCLX Comparison

Compare CISO & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CISO
  • SCLX
  • Stock Information
  • Founded
  • CISO 2015
  • SCLX 2011
  • Country
  • CISO United States
  • SCLX United States
  • Employees
  • CISO N/A
  • SCLX N/A
  • Industry
  • CISO Computer Software: Prepackaged Software
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CISO Technology
  • SCLX Health Care
  • Exchange
  • CISO Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • CISO 31.4M
  • SCLX 35.7M
  • IPO Year
  • CISO N/A
  • SCLX N/A
  • Fundamental
  • Price
  • CISO $1.29
  • SCLX $24.96
  • Analyst Decision
  • CISO
  • SCLX Strong Buy
  • Analyst Count
  • CISO 0
  • SCLX 3
  • Target Price
  • CISO N/A
  • SCLX $367.50
  • AVG Volume (30 Days)
  • CISO 685.4K
  • SCLX 205.7K
  • Earning Date
  • CISO 11-17-2025
  • SCLX 08-13-2025
  • Dividend Yield
  • CISO N/A
  • SCLX N/A
  • EPS Growth
  • CISO N/A
  • SCLX N/A
  • EPS
  • CISO N/A
  • SCLX N/A
  • Revenue
  • CISO $28,792,765.00
  • SCLX $44,236,000.00
  • Revenue This Year
  • CISO N/A
  • SCLX $89.26
  • Revenue Next Year
  • CISO N/A
  • SCLX $203.95
  • P/E Ratio
  • CISO N/A
  • SCLX N/A
  • Revenue Growth
  • CISO N/A
  • SCLX N/A
  • 52 Week Low
  • CISO $0.30
  • SCLX $3.60
  • 52 Week High
  • CISO $3.84
  • SCLX $39.90
  • Technical
  • Relative Strength Index (RSI)
  • CISO 68.68
  • SCLX 64.44
  • Support Level
  • CISO $1.21
  • SCLX $22.45
  • Resistance Level
  • CISO $1.47
  • SCLX $27.58
  • Average True Range (ATR)
  • CISO 0.11
  • SCLX 2.32
  • MACD
  • CISO 0.04
  • SCLX 0.09
  • Stochastic Oscillator
  • CISO 70.30
  • SCLX 74.71

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: